Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James F Casella

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Pediatrics|April 16, 2002
Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial strokeDouglas J Scothorn, Cynthia Price, Daniel Schwartz, et al.
Lancet (London, England)|May 17, 2011
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)Winfred C Wang, Russell E Ware, Scott T Miller, et al.
JAMA|March 3, 2011
Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trialMark T Gladwin, Gregory J Kato, Debra Weiner, et al.
Nature Communications|March 2, 2025
FLT1 and other candidate fetal haemoglobin modifying loci in sickle cell disease in African ancestriesAmbroise Wonkam, Kevin Esoh, Rachel M Levine, et al.
American Journal of Hematology|July 22, 2014
Silent cerebral infarction, income, and grade retention among students with sickle cell anemiaAllison A King, Mark J Rodeghier, Julie Ann Panepinto, et al.
American Journal of Hematology|July 2, 2024
Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot studyJames F Casella, Dana K Furstenau, Robert J Adams, et al.
Blood|November 19, 2011
Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressureMichael R DeBaun, Sharada A Sarnaik, Mark J Rodeghier, et al.
Contemporary Clinical Trials|May 5, 2026
Conducting multicenter trials through the trial innovation network comprehensive consultationDaniel F Hanley, Karen Lane, Nichol McBee, et al.
The New England Journal of Medicine|August 21, 2014
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemiaMichael R DeBaun, Mae Gordon, Robert C McKinstry, et al.
Journal of Clinical and Translational Science|July 30, 2025
Insights from the trial innovation network's initial consultation processPaul A Harris, Nan Kennedy, Consuelo H Wilkins, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Pediatrics|April 16, 2002
Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial strokeDouglas J Scothorn, Cynthia Price, Daniel Schwartz, et al.
Lancet (London, England)|May 17, 2011
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)Winfred C Wang, Russell E Ware, Scott T Miller, et al.
JAMA|March 3, 2011
Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trialMark T Gladwin, Gregory J Kato, Debra Weiner, et al.
Nature Communications|March 2, 2025
FLT1 and other candidate fetal haemoglobin modifying loci in sickle cell disease in African ancestriesAmbroise Wonkam, Kevin Esoh, Rachel M Levine, et al.
American Journal of Hematology|July 22, 2014
Silent cerebral infarction, income, and grade retention among students with sickle cell anemiaAllison A King, Mark J Rodeghier, Julie Ann Panepinto, et al.
American Journal of Hematology|July 2, 2024
Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot studyJames F Casella, Dana K Furstenau, Robert J Adams, et al.
Blood|November 19, 2011
Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressureMichael R DeBaun, Sharada A Sarnaik, Mark J Rodeghier, et al.
Contemporary Clinical Trials|May 5, 2026
Conducting multicenter trials through the trial innovation network comprehensive consultationDaniel F Hanley, Karen Lane, Nichol McBee, et al.
The New England Journal of Medicine|August 21, 2014
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemiaMichael R DeBaun, Mae Gordon, Robert C McKinstry, et al.
Journal of Clinical and Translational Science|July 30, 2025
Insights from the trial innovation network's initial consultation processPaul A Harris, Nan Kennedy, Consuelo H Wilkins, et al.
Pageof 10